RSS feed

Publications by Stefan Agewall

362 publications found

Original articles

Agewall S (2024)
New data on NOVEL ORAL ANTICOAGULANT, SGLT2i, lipid treatment and genetics
Eur Heart J Cardiovasc Pharmacother, 10 (2), 83-84
DOI 10.1093/ehjcvp/pvae005, PubMed 38366031

Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Magavern E, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D (2024)
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvae013, PubMed 38379024

Xiong W, Agewall S, Yamashita Y (2024)
Anticoagulation in cancer-associated thrombosis: how long should the therapy be?
Eur Heart J Cardiovasc Pharmacother, 10 (1), 3-4
DOI 10.1093/ehjcvp/pvad075, PubMed 37827545

Agewall S (2024)
Cardiovascular prevention and risk factors
Eur Heart J Cardiovasc Pharmacother, 10 (1), 1-2
DOI 10.1093/ehjcvp/pvad087, PubMed 38000082

Agewall S (2023)
The search for the perfect antiplatelet treatment continues
Eur Heart J Cardiovasc Pharmacother, 9 (8), 671-672
DOI 10.1093/ehjcvp/pvad079, PubMed 38093457

Seekircher L, Tschiderer L, Lind L, Safarova MS, Kavousi M, Ikram MA, Lonn E, Yusuf S, Grobbee DE, Kastelein JJP, Visseren FLJ, Walters M, Dawson J, Higgins P, Agewall S, Catapano A, de Groot E, Espeland MA, Klingenschmid G, Magliano D, Olsen MH, Preiss D, Sander D, Skilton M, Zozulińska-Ziółkiewicz DA et al. (2023)
Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment
Eur Heart J Open, 3 (5), oead089
DOI 10.1093/ehjopen/oead089, PubMed 37840587

Wärme J, Sundqvist MO, Hjort M, Agewall S, Collste O, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Spaak J, Sörensson P, Y-Hassan S, Svensson P, Lindahl B, Hofmann R, Tornvall P (2023)
Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease
Int J Mol Sci, 24 (18)
DOI 10.3390/ijms241814143, PubMed 37762446

Berg E, Agewall S, Brolin EB, Caidahl K, Cederlund K, Collste O, Daniel M, Ekenbäck C, Jensen J, Y-Hassan S, Henareh L, Maret E, Spaak J, Sörensson P, Tornvall P, Lyngå P (2023)
Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries
Eur Heart J Qual Care Clin Outcomes, 9 (6), 639-644
DOI 10.1093/ehjqcco/qcac072, PubMed 36328780

Fröhlich H, Bossmeyer A, Kazmi S, Goode KM, Agewall S, Atar D, Grundtvig M, Frey N, Cleland JGF, Frankenstein L, Clark AL, Täger T (2023)
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus
Clin Res Cardiol (in press)
DOI 10.1007/s00392-023-02268-3, PubMed 37608126

Tjessum L, Agewall S (2023)
Evaluation of a Structuralized Sick-Leave Programme Compared with usual Care Sick-Leave Management for Patients after an Acute Myocardial Infarction
J Rehabil Med, 55, jrm4569
DOI 10.2340/jrm.v55.4569, PubMed 37486246

Tschiderer L, Seekircher L, Izzo R, Mancusi C, Manzi MV, Baldassarre D, Amato M, Tremoli E, Veglia F, Tuomainen TP, Kauhanen J, Voutilainen A, Iglseder B, Lind L, Rundek T, Desvarieux M, Kato A, de Groot E, Aşçi G, Ok E, Agewall S, Beulens JWJ, Byrne CD, Calder PC, Gerstein HC et al. (2023)
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies
J Am Heart Assoc, 12 (12), e027657
DOI 10.1161/JAHA.122.027657, PubMed 37301757

Agewall S (2023)
Focus on prevention in diabetes mellitus and lipid disorder
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvad037, PubMed 37259181

Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D (2023)
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
Eur Heart J Cardiovasc Pharmacother, 9 (4), 353-70 (in press)
DOI 10.1093/ehjcvp/pvad034, PubMed 37169875

Agewall S (2023)
A tailor-made suit always fits best
Eur Heart J Cardiovasc Pharmacother, 9 (3), 199-200
DOI 10.1093/ehjcvp/pvad024, PubMed 37036066

Nguyen THP, Fagerland MW, Hollan I, Whist JE, Feinberg MW, Agewall S (2023)
High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
PLoS One, 18 (2), e0281155
DOI 10.1371/journal.pone.0281155, PubMed 36763689

Drexel H, Saely CH, Agewall S (2023)
Fibrates: one more lost paradise in lipid treatment
Eur Heart J Cardiovasc Pharmacother, 9 (2), 121
DOI 10.1093/ehjcvp/pvac072, PubMed 36610735

Hokstad I, Greco D, Deyab G, Fagerland MW, Agewall S, Hjeltnes G, Zimetti F, Bernini F, Ronda N, Hollan I (2022)
Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
J Clin Med, 11 (24)
DOI 10.3390/jcm11247330, PubMed 36555946

Martínez-Montesinos L, Rivera-Caravaca JM, Agewall S, Soler E, Lip GYH, Marín F, Roldán V (2022)
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomed Pharmacother, 158, 114064
DOI 10.1016/j.biopha.2022.114064, PubMed 36495662

Komiyama M, Agewall S, Hasegawa K (2022)
Future of antithrombotic therapy for heart failure with coronary artery disease
Eur Heart J Cardiovasc Pharmacother, 8 (5), e25
DOI 10.1093/ehjcvp/pvac030, PubMed 35521703

Nguyen THP, Hokstad I, Fagerland MW, Mollnes TE, Hollan I, Feinberg MW, Hjeltnes G, Eilertsen GØ, Mikkelsen K, Agewall S (2022)
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
PLoS One, 17 (2), e0264628
DOI 10.1371/journal.pone.0264628, PubMed 35213675

El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS, Savarese G (2022)
Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
Eur Heart J Cardiovasc Pharmacother, 8 (2), 187-210
DOI 10.1093/ehjcvp/pvaa108, PubMed 32941594

Hall TS, Ørn S, Zannad F, Rossignol P, Duarte K, Solomon SD, Atar D, Agewall S, Dickstein K, Girerd N (2022)
The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction
J Womens Health (Larchmt), 31 (3), 310-320
DOI 10.1089/jwh.2021.0326, PubMed 35049355

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ (2022)
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (1), 85-99
DOI 10.1093/ehjcvp/pvab018, PubMed 33638977

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ (2022)
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (1), 100-103
DOI 10.1093/ehjcvp/pvab063, PubMed 34463331

Svenungsson E, Spaak J, Strandberg K, Wallén HN, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Malmqvist K, Elvin K, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P (2021)
Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
J Intern Med, 291 (3), 327-337
DOI 10.1111/joim.13409, PubMed 34820922

Y-Hassan S, Sörensson P, Ekenbäck C, Lundin M, Agewall S, Brolin EB, Caidahl K, Cederlund K, Collste O, Daniel M, Jensen J, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Ugander M, Tornvall P, Henareh L (2021)
Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study
Clin Cardiol, 44 (11), 1567-1574
DOI 10.1002/clc.23723, PubMed 34490898

Deyab G, Reine TM, Vuong TT, Jenssen T, Hjeltnes G, Agewall S, Mikkelsen K, Førre Ø, Fagerland MW, Kolset SO, Hollan I (2021)
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
PLoS One, 16 (7), e0253247
DOI 10.1371/journal.pone.0253247, PubMed 34242246

Nguyen THP, Fagerland MW, Deyab G, Hjeltnes G, Hollan I, Feinberg MW, Eilertsen GØ, Mikkelsen K, Agewall S (2021)
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
PLoS One, 16 (6), e0253793
DOI 10.1371/journal.pone.0253793, PubMed 34170978

Sörensson P, Ekenbäck C, Lundin M, Agewall S, Bacsovics Brolin E, Caidahl K, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Ugander M, Tornvall P (2021)
Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
JACC Cardiovasc Imaging, 14 (9), 1774-1783
DOI 10.1016/j.jcmg.2021.02.021, PubMed 33865778

Nordenskjöld AM, Agewall S, Atar D, Baron T, Beltrame J, Bergström O, Erlinge D, Gale CP, López-Pais J, Jernberg T, Johansson P, Ravn-Fisher A, Reynolds HR, Somaratne JB, Tornvall P, Lindahl B (2020)
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design
Am Heart J, 231, 96-104
DOI 10.1016/j.ahj.2020.10.059, PubMed 33203618

Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, Brouwers FP, Asselbergs FW, van Gilst W, Anderssen SA, Grobbee DE, Kastelein JJP, Visseren FLJ, Ntaios G, Hatzitolios AI, Savopoulos C, Nieuwkerk PT, Stroes E, Walters M, Higgins P, Dawson J et al. (2020)
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Circulation, 142 (7), 621-642
DOI 10.1161/CIRCULATIONAHA.120.046361, PubMed 32546049

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ et al. (2020)
2019 ESC Guide on the Diagnosis and Treatment of Chronic Coronary Syndromes
Rev. Esp. Cardiol., 73 (6)
DOI 10.1016/j.recesp.2019.10.032

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ et al. (2020)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Eur Heart J, 41 (3), 407-477
DOI 10.1093/eurheartj/ehz425, PubMed 31504439

Tschiderer L, Seekircher L, Klingenschmid G, Izzo R, Baldassarre D, Iglseder B, Calabresi L, Liu J, Price JF, Bae JH, Brouwers FP, de Groot E, Schmidt C, Bergström G, Aşçi G, Gresele P, Okazaki S, Kapellas K, Landecho MF, Sattar N, Agewall S, Zou ZY, Byrne CD, Nanayakkara PWB, Papagianni A et al. (2020)
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale
Gerontology, 66 (5), 447-459
DOI 10.1159/000508498, PubMed 32610336

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Cardiovasc Res, 115 (14), e187-e188
DOI 10.1093/cvr/cvz007, PubMed 30689762

Bahls M, Lorenz MW, Dörr M, Gao L, Kitagawa K, Tuomainen TP, Agewall S, Berenson G, Catapano AL, Norata GD, Bots ML, van Gilst W, Asselbergs FW, Brouwers FP, Uthoff H, Sander D, Poppert H, Hecht Olsen M, Empana JP, Schminke U, Baldassarre D, Veglia F, Franco OH, Kavousi M, de Groot E et al. (2019)
Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium
Eur J Prev Cardiol, 27 (3), 234-243
DOI 10.1177/2047487319877078, PubMed 31619084

Serebruany VL, Hall TS, Atar D, Agewall S, Hyun Kim M, Geudelin B, Lomakin N, Marciniak TA (2019)
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
Eur Heart J Cardiovasc Pharmacother, 5 (4), 210-215
DOI 10.1093/ehjcvp/pvy035, PubMed 30192939

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A (2019)
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1
Eur Heart J, 40 (36), 3010-3012
DOI 10.1093/eurheartj/ehz650, PubMed 31541549

Hokstad I, Deyab G, Wang Fagerland M, Lyberg T, Hjeltnes G, Førre Ø, Agewall S, Mollnes TE, Hollan I (2019)
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
PLoS One, 14 (7), e0220079
DOI 10.1371/journal.pone.0220079, PubMed 31335881

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Solomon SD, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2019)
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Am Heart J, 215, 83-90
DOI 10.1016/j.ahj.2019.06.004, PubMed 31291604

Hjort M, Eggers KM, Lindhagen L, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Malmqvist K, Spaak J, Sörensson P, Y-Hassan S, Tornvall P, Lindahl B (2019)
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries
Clin Chem, 65 (8), 1023-1030
DOI 10.1373/clinchem.2018.301085, PubMed 31072836

Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, Lerman A, Cushman M, Kumbhani DJ, Arslanian-Engoren C, Bolger AF, Beltrame JF, American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research (2019)
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association
Circulation, 139 (18), e891-e908
DOI 10.1161/CIR.0000000000000670, PubMed 30913893

Hausvater A, Pasupathy S, Tornvall P, Gandhi H, Tavella R, Beltrame J, Agewall S, Ekenbäck C, Brolin EB, Hochman JS, Collste O, Reynolds HR (2019)
ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries
Int J Cardiol, 287, 128-131
DOI 10.1016/j.ijcard.2019.04.028, PubMed 31003795

Fröhlich H, Rosenfeld N, Täger T, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L, Grundtvig M (2019)
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
Heart, 105 (16), 1252-1259
DOI 10.1136/heartjnl-2018-314256, PubMed 30792238

Agewall S (2019)
EHJ Cardiovascular Pharmacotherapy has Impact Factor
Eur Heart J, 40 (7), 572
DOI 10.1093/eurheartj/ehy897, PubMed 30768210

Täger T, Fröhlich H, Grundtvig M, Seiz M, Schellberg D, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L (2019)
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
Int J Cardiol, 289, 83-90
DOI 10.1016/j.ijcard.2019.01.109, PubMed 30827731

Hill JA, following HEART Group Signatories, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV et al. (2019)
Medical Misinformation: Vet the Message!
Eur Heart J, 40 (5), 404-405
DOI 10.1093/eurheartj/ehz009, PubMed 30689805

Rosano GMC, Spoletini I, Agewall S (2019)
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
Eur Heart J Suppl, 21 (Suppl A), A28-A33
DOI 10.1093/eurheartj/suy035, PubMed 30837802

von Lueder TG, Atar D, Agewall S, Jensen JK, Hopper I, Kotecha D, Mentz RJ, Kim MH, Serebruany VL (2019)
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
Am J Ther, 26 (6), e671-e678
DOI 10.1097/MJT.0000000000000883, PubMed 31145139

Nero D, Agewall S, Daniel M, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sörensson P, Sundin Ö, Y-Hassan S, Hofman-Bang C, Tornvall P (2018)
Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries
Am J Med, 132 (3), 374-381.e1
DOI 10.1016/j.amjmed.2018.11.010, PubMed 30503881

Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS (2018)
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 4 (3), 180-188
DOI 10.1093/ehjcvp/pvy015, PubMed 29726985

Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS (2018)
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J, 39 (24), 2274-2281
DOI 10.1093/eurheartj/ehx625, PubMed 29126266

Daniel M, Agewall S, Berglund F, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sundin Ö, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P (2018)
Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries
Am J Med, 131 (9), 1118-1124
DOI 10.1016/j.amjmed.2018.04.040, PubMed 29859805

Deyab G, Hokstad I, Aaseth J, Småstuen MC, Whist JE, Agewall S, Lyberg T, Tveiten D, Hjeltnes G, Zibara K, Hollan I (2018)
Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis
J Trace Elem Med Biol, 49, 91-97
DOI 10.1016/j.jtemb.2018.05.001, PubMed 29895378

Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C, ESC Scientific Document Group (2018)
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Europace, 20 (5), 731-732an
DOI 10.1093/europace/eux373, PubMed 29438514

Fröhlich H, Henning F, Täger T, Schellberg D, Grundtvig M, Goode K, Corletto A, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Frankenstein L, Clark AL (2018)
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
Eur Heart J Cardiovasc Pharmacother, 4 (2), 82-92
DOI 10.1093/ehjcvp/pvx013, PubMed 28475676

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P, ESC Scientific Document Group (2018)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 39 (2), 119-177
DOI 10.1093/eurheartj/ehx393, PubMed 28886621

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P (2018)
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]
Kardiol Pol, 76 (2), 229-313
DOI 10.5603/KP.2018.0041, PubMed 29457615

Ibánez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P (2017)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Rev Esp Cardiol (Engl Ed), 70 (12), 1082
DOI 10.1016/j.rec.2017.11.010, PubMed 29198432

Deyab G, Hokstad I, Whist JE, Smastuen MC, Agewall S, Lyberg T, Ronda N, Mikkelsen K, Hjeltnes G, Hollan I (2017)
Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
Arthritis Res Ther, 19 (1), 232
DOI 10.1186/s13075-017-1439-1, PubMed 29041979

Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Roffi M, Alfieri O, Agewall S, Ahlsson A, Barbato E, Bueno H, Collet JP et al. (2017)
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]
Eur J Cardiothorac Surg, 52 (4), 832
DOI 10.1093/ejcts/ezx363, PubMed 29206961

Agewall S, Tjessem LH, Rossignol P, Zannad F, Atar D, Lamiral Z, Machu JL, Dickstein K, Kjekshus J, von Lueder TG, Girerd N, High Risk Myocardial Infarction Database Initiative investigators (2017)
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
Int J Cardiol, 249, 274-281
DOI 10.1016/j.ijcard.2017.09.182, PubMed 28964557

Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H (2017)
Comprehensive efforts to increase adherence to statin therapy
Eur Heart J, 38 (32), 2473-2479
DOI 10.1093/eurheartj/ehw628, PubMed 28077470

Tornvall P, Brolin EB, Caidahl K, Cederlund K, Collste O, Daniel M, Ekenbäck C, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Sundqvist M, Sörensson P, Ugander M, Agewall S (2017)
The value of a new cardiac magnetic resonance imaging protocol in Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA) - a case-control study using historical controls from a previous study with similar inclusion criteria
BMC Cardiovasc Disord, 17 (1), 199
DOI 10.1186/s12872-017-0611-5, PubMed 28738781

Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, Torp-Pedersen C, Kjeldsen K, Lewis BS, Drexel H, Kaski JC, Atar D, Storey RF, Lip GYH, Verheugt FWA, Agewall S (2017)
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
Eur Heart J, 38 (22), 1710-1716
DOI 10.1093/eurheartj/ehv676, PubMed 26705385

Daniel M, Agewall S, Caidahl K, Collste O, Ekenbäck C, Frick M, Y-Hassan S, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Sörensson P, Sundin Ö, Hofman-Bang C, Tornvall P (2017)
Effect of Myocardial Infarction With Nonobstructive Coronary Arteries on Physical Capacity and Quality-of-Life
Am J Cardiol, 120 (3), 341-346
DOI 10.1016/j.amjcard.2017.05.001, PubMed 28610801

Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L (2017)
Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
Clin Res Cardiol, 106 (9), 711-721
DOI 10.1007/s00392-017-1115-0, PubMed 28434020

Lorenz MW, Abdi NA, Scheckenbach F, Pflug A, Bülbül A, Catapano AL, Agewall S, Ezhov M, Bots ML, Kiechl S, Orth A, PROG-IMT study group (2017)
Automatic identification of variables in epidemiological datasets using logic regression
BMC Med Inform Decis Mak, 17 (1), 40
DOI 10.1186/s12911-017-0429-1, PubMed 28407816

Fröhlich H, Raman N, Täger T, Schellberg D, Goode KM, Kazmi S, Grundtvig M, Hole T, Cleland JGF, Katus HA, Agewall S, Clark AL, Atar D, Frankenstein L (2017)
Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure
Int J Cardiol, 238, 97-104
DOI 10.1016/j.ijcard.2017.03.028, PubMed 28342630

Deyab G, Hokstad I, Whist JE, Småstuen MC, Agewall S, Lyberg T, Bottazzi B, Meroni PL, Leone R, Hjeltnes G, Hollan I (2017)
Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
PLoS One, 12 (2), e0169830
DOI 10.1371/journal.pone.0169830, PubMed 28225768

Brolin EB, Agewall S, Cederlund K, Ekenbäck C, Henareh L, Malmqvist K, Rück A, Svensson A, Tornvall P (2017)
Plasma biomarker levels and non-obstructive coronary artery disease determined by coronary computed tomography angiography
Clin Physiol Funct Imaging, 38 (2), 246-253
DOI 10.1111/cpf.12407, PubMed 28168796

Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, Halle M, Kudaiberdieva G, Lane DA, Larsen TB, Lip GY, Løchen ML, Marín F, Niebauer J, Sanders P, Tokgozoglu L, Vos MA, Van Wagoner DR, Fauchier L, Savelieva I, Goette A, Agewall S, Chiang CE, Figueiredo M et al. (2017)
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Europace, 19 (2), 190-225
DOI 10.1093/europace/euw242, PubMed 28175283

Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P, WG on Cardiovascular Pharmacotherapy (2017)
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
Eur Heart J, 38 (3), 143-153
DOI 10.1093/eurheartj/ehw149, PubMed 28158518

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I et al. (2017)
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation]
G Ital Cardiol (Rome), 18 (7), 547-612
DOI 10.1714/2729.27821, PubMed 28714997

Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, Halle M, Kudaiberdieva G, Lane DA, Bjerregaard Larsen T, Lip GY, Løchen ML, Marin F, Niebauer J, Sanders P, Tokgozoglu L, Vos MA, Van Wagoner DR, Document reviewers:, Fauchier L, Savelieva I, Goette A, Agewall S, Chiang CE et al. (2016)
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Eur J Prev Cardiol, 24 (1), 4-40
DOI 10.1177/2047487316676037, PubMed 27815538

Perk J, Agewall S, Kiessling A (2016)
[A healthy lifestyle in focus of new guidelines]
Lakartidningen, 113
PubMed 27779726

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Richard Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H, van Dis I et al. (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Rev Esp Cardiol (Engl Ed), 69 (10), 939
DOI 10.1016/j.rec.2016.09.009, PubMed 27692125

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R et al. (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Eur J Cardiothorac Surg, 50 (5), e1-e88
DOI 10.1093/ejcts/ezw313, PubMed 27663299

Authors/Task Force Members:, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H et al. (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Atherosclerosis, 252, 207-274
DOI 10.1016/j.atherosclerosis.2016.05.037, PubMed 27664503

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R et al. (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Europace, 18 (11), 1609-1678
DOI 10.1093/europace/euw295, PubMed 27567465

Authors/Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB et al. (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Eur J Prev Cardiol, 23 (11), NP1-NP96
DOI 10.1177/2047487316653709, PubMed 27353126

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I et al. (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Eur Heart J, 37 (29), 2315-2381
DOI 10.1093/eurheartj/ehw106, PubMed 27222591

Catalano M, Poredos P, Brodmann M, Wautrecht JC, Carpentier P, Roztocil K, Nikol S, Dimakakos EP, Marakomichelakis G, Pecsvarady Z, Carlizza A, Sieron A, Stanek A, Olinic D, Stvrtinova V, Kozak M, Agewall S, Amann-Vesti B, Gallino A, Fitzgerald P, Colgan MP (2016)
UEMS training requirements for angiology and vascular medicine: european standards of postgraduate medical specialist training (ETR Document)
Int Angiol, 35 (2), 217-31
PubMed 26883441

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney M, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I et al. (2016)
[2016 European Guidelines on cardiovascular disease prevention in clinical practice]
Kardiol Pol, 74 (9), 821-936
DOI 10.5603/KP.2016.0120, PubMed 27654471

von Lueder TG, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M, Pitt B, Dickstein K, Zannad F, Rossignol P, High-Risk Myocardial Infarction Database Initiative Investigators (2015)
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
Eur J Heart Fail, 17 (11), 1144-51
DOI 10.1002/ejhf.419, PubMed 26424212

Fröhlich H, Zhao J, Täger T, Cebola R, Schellberg D, Katus HA, Grundtvig M, Hole T, Atar D, Agewall S, Frankenstein L (2015)
Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study
Circ Heart Fail, 8 (5), 887-96
DOI 10.1161/CIRCHEARTFAILURE.114.001701, PubMed 26175538

Brolin EB, Agewall S, Brismar TB, Caidahl K, Tornvall P, Cederlund K (2015)
Neither endothelial function nor carotid artery intima-media thickness predicts coronary computed tomography angiography plaque burden in clinically healthy subjects: a cross-sectional study
BMC Cardiovasc Disord, 15, 63
DOI 10.1186/s12872-015-0061-x, PubMed 26148508

Daniel M, Ekenbäck C, Agewall S, Brolin EB, Caidahl K, Cederlund K, Collste O, Eurenius L, Frick M, Younis-Hassan S, Henareh L, Jernberg T, Malmqvist K, Spaak J, Sörensson P, Hofman-Bang C, Tornvall P (2015)
Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary Arteries
Am J Cardiol, 116 (6), 838-44
DOI 10.1016/j.amjcard.2015.06.011, PubMed 26251000

Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J (2015)
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC
Eur Heart J, 36 (40), 2677-80
DOI 10.1093/eurheartj/ehv161, PubMed 25948737

Tornvall P, Gerbaud E, Behaghel A, Chopard R, Collste O, Laraudogoitia E, Leurent G, Meneveau N, Montaudon M, Perez-David E, Sörensson P, Agewall S (2015)
Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data
Atherosclerosis, 241 (1), 87-91
DOI 10.1016/j.atherosclerosis.2015.04.816, PubMed 25967935

De Blois J, Fagerland MW, Grundtvig M, Semb AG, Gullestad L, Westheim A, Hole T, Atar D, Agewall S (2015)
ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
Eur Heart J Cardiovasc Pharmacother, 1 (1), 31-6
DOI 10.1093/ehjcvp/pvu010, PubMed 27533962

De Blois J, Kjellstrom T, Agewall S, Ezekowitz JA, Armstrong PW, Atar D (2015)
The Effects of Climate Change on Cardiac Health
Cardiology, 131 (4), 209-17
DOI 10.1159/000398787, PubMed 25997478

Willeit P, Thompson SG, Agewall S, Bergström G, Bickel H, Catapano AL, Chien KL, de Groot E, Empana JP, Etgen T, Franco OH, Iglseder B, Johnsen SH, Kavousi M, Lind L, Liu J, Mathiesen EB, Norata GD, Olsen MH, Papagianni A, Poppert H, Price JF, Sacco RL, Yanez DN, Zhao D et al. (2014)
Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
Eur J Prev Cardiol, 23 (2), 194-205
DOI 10.1177/2047487314560664, PubMed 25416041

Hall TS, Hallén J, Krucoff MW, Roe MT, Brennan DM, Agewall S, Atar D, Lincoff AM (2014)
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Am Heart J, 169 (2), 257-265.e1
DOI 10.1016/j.ahj.2014.10.015, PubMed 25641535

Omland T, Røsjø H, Giannitsis E, Agewall S (2014)
Troponins in heart failure
Clin Chim Acta, 443, 78-84
DOI 10.1016/j.cca.2014.08.016, PubMed 25151947

Hall TS, Herrscher TE, Jarolim P, Fagerland MW, Jensen T, Agewall S, Atar D, Hallén J (2014)
Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea
Sleep Med, 15 (7), 762-8
DOI 10.1016/j.sleep.2014.03.008, PubMed 24841106

Agewall S (2014)
[New guidelines for diagnosis and management of stable angina pectoris. Recommendations from the European Society of Cardiology]
Lakartidningen, 111 (15), 680-1
PubMed 24864514

Agewall S (2014)
[New guidelines for angina pectoris]
Tidsskr Nor Laegeforen, 134 (5), 510
DOI 10.4045/tidsskr.13.1552, PubMed 24621907

Agewall S, Giannitsis E (2014)
"Troponin elevation in coronary ischemia and necrosis"
Curr Atheroscler Rep, 16 (3), 396
DOI 10.1007/s11883-013-0396-7, PubMed 24425063

Johnson J, Manouras A, Bergholm F, Brodin LÅ, Agewall S, Henareh L (2013)
The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease
Clin Physiol Funct Imaging, 34 (5), 389-96
DOI 10.1111/cpf.12110, PubMed 24438358

Catalano M, Poredos P, Brodmann M, Wautrecht JC, Carpentier P, Roztocil K, Nikol S, Diamantopoulos E, Pecsvarady Z, Carlizza A, Sieron A, Stanek A, Olinic D, Stvrtinova V, Kozak M, Agewall S, Gallino A, Jaeger KA, Fitzgerald P, Colgan MP (2013)
Requirements for angiology/vascular medicine
Int Angiol, 32 (6), 608-12
PubMed 24212296

Crisby M, Henareh L, Agewall S (2013)
Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction
Angiology, 65 (10), 932-6
DOI 10.1177/0003319713512720, PubMed 24288363

Jogestrand T, Agewall S, Gustafsson T, Henareh L (2013)
Conventional treatment after myocardial infarction in routine clinical practice results in regression of left common carotid intima-media thickness
Clin Physiol Funct Imaging, 34 (4), 322-6
DOI 10.1111/cpf.12101, PubMed 24237780

Hall TS, Herrscher T, Jarolim P, Fagerland MW, Jensen T, Hallén J, Agewall S, Atar D (2013)
Obstructive sleep apnea: no independent association to troponins
Sleep Breath, 18 (2), 351-8
DOI 10.1007/s11325-013-0892-6, PubMed 24043484

Frankenstein L, Katus HA, Grundtvig M, Hole T, de Blois J, Schellberg D, Atar D, Zugck C, Agewall S, Norwegian Heart Failure Registry steering committee (2013)
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study
Eur J Clin Pharmacol, 69 (10), 1747-55
DOI 10.1007/s00228-013-1512-x, PubMed 23743778

Agewall S (2013)
[New European guidelines for heart failure]
Tidsskr Nor Laegeforen, 133 (7), 739
DOI 10.4045/tidsskr.12.1485, PubMed 23588176

Ghanavatian S, Diep LM, Bárány P, Heimbürger O, Seeberger A, Stenvinkel P, Rohani M, Agewall S (2013)
Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4
Angiology, 65 (5), 443-9
DOI 10.1177/0003319713483000, PubMed 23567479

Agewall S, Rydén L, Perk J, Rosengren A, Boman K, Hellénius ML, Ros I (2013)
[Wanted: Politics against heart attacks]
Lakartidningen, 110 (13-14), 664
PubMed 23634619

Agewall S (2013)
[New European guidelines for acute and chronic heart failure]
Lakartidningen, 110 (13-14), 672-3
PubMed 23634620

Scheiman JM, Herlitz J, Veldhuyzen van Zanten SJ, Lanas A, Agewall S, Nauclér EC, Svedberg LE, Nagy P (2013)
Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial
J Cardiovasc Pharmacol, 61 (3), 250-7
DOI 10.1097/FJC.0b013e31827cb626, PubMed 23188121

Agewall S, Cattaneo M, Collet JP, Andreotti F, Lip GY, Verheugt FW, Huber K, Grove EL, Morais J, Husted S, Wassmann S, Rosano G, Atar D, Pathak A, Kjeldsen K, Storey RF, ESC Working Group on Cardiovascular Pharmacology and Drug Therapy and ESC Working Group on Thrombosis (2013)
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
Eur Heart J, 34 (23), 1708-13, 1713a-1713b
DOI 10.1093/eurheartj/eht042, PubMed 23425521

Verheugt FW, Clemmensen P, Mehran R, Agewall S, Pocock SJ, Goldstein S, Torp-Pedersen C, Simoons ML, Borer JS, Khder YM, Burton P, Deliargyris E, McMurray JJ, Berkowitz SD, Stough WG, Zannad F (2013)
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy
Eur Heart J, 34 (22), 1621-9
DOI 10.1093/eurheartj/eht013, PubMed 23382466

Hjeltnes G, Hollan I, Førre O, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2013)
Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor
Clin Exp Rheumatol, 31 (3), 415-21
PubMed 23465067

Namtvedt SK, Hisdal J, Randby A, Agewall S, Stranden E, Somers VK, Røsjø H, Omland T (2012)
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity
Heart, 99 (1), 30-4
DOI 10.1136/heartjnl-2012-303009, PubMed 23048165

Henareh L, Agewall S (2012)
2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus
Cardiovasc Diabetol, 11, 93
DOI 10.1186/1475-2840-11-93, PubMed 22873202

Collste O, Sörensson P, Frick M, Agewall S, Daniel M, Henareh L, Ekenbäck C, Eurenius L, Guiron C, Jernberg T, Hofman-Bang C, Malmqvist K, Nagy E, Arheden H, Tornvall P (2012)
Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study
J Intern Med, 273 (2), 189-96
DOI 10.1111/j.1365-2796.2012.02567.x, PubMed 22742529

Hjeltnes G, Hollan I, Førre Ø, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2012)
Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors
J Rheumatol, 39 (7), 1341-7
DOI 10.3899/jrheum.111401, PubMed 22660798

De Blois J, Stranden E, Jogestrand T, Henareh L, Agewall S (2012)
Echogenicity of the carotid intima-media complex and cardiovascular risk factors
Clin Physiol Funct Imaging, 32 (5), 400-3
DOI 10.1111/j.1475-097X.2012.01134.x, PubMed 22856348

Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, European Society of Cardiology (2012)
[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]
G Ital Cardiol (Rome), 13 (3), 171-228
DOI 10.1714/1038.11322, PubMed 22395108

Melki D, Lind S, Agewall S, Jernberg T (2012)
Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation
Clin Chim Acta, 413 (9-10), 933-7
DOI 10.1016/j.cca.2012.02.008, PubMed 22366164

Agewall S (2012)
[Troponin can be increased in healthy persons following moderate exercise]
Lakartidningen, 109 (1-2), 18
PubMed 22468405

Hall TS, Hallén J, Agewall S, Atar D, Jensen T (2012)
Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience
Clin Lab, 58 (9-10), 1029-36
DOI 10.7754/Clin.Lab.2012.111206, PubMed 23163120

Agewall S, Daniel M, Eurenius L, Ekenbäck C, Skeppholm M, Malmqvist K, Hofman-Bang C, Collste O, Frick M, Henareh L, Jernberg T, Tornvall P (2011)
Risk factors for myocardial infarction with normal coronary arteries and myocarditis compared with myocardial infarction with coronary artery stenosis
Angiology, 63 (7), 500-3
DOI 10.1177/0003319711429560, PubMed 22210737

Agewall S (2011)
[New European guidelines for myocardial infarction without ST-segment elevation. Quicker diagnosis saves money--demands for angiography also during weekends costs more]
Lakartidningen, 108 (50), 2644-5
PubMed 22474779

Agewall S, Atar D (2011)
[New European guidelines for acute myocardial infarction]
Tidsskr Nor Laegeforen, 131 (23), 2340
DOI 10.4045/tidsskr.11.1133, PubMed 22139110

Agewall S, Tjora S (2011)
Physical exertion may cause high troponin levels
Tidsskr Nor Laegeforen, 131 (22), 2226
DOI 10.4045/tidsskr.11.0815, PubMed 22085943

Hjeltnes G, Hollan I, Førre Ø, Wiik A, Mikkelsen K, Agewall S (2011)
Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients
Scand J Rheumatol, 40 (6), 422-7
DOI 10.3109/03009742.2011.585350, PubMed 22150462

Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Committee for Practice Guidelines (2011)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 32 (23), 2999-3054
DOI 10.1093/eurheartj/ehr236, PubMed 21873419

European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees (2011)
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Eur Heart J, 32 (14), 1769-818
DOI 10.1093/eurheartj/ehr158, PubMed 21712404

Agewall S (2011)
Some aspects of preventing coronary heart disease
Angiology, 63 (1), 17-23
DOI 10.1177/0003319711407060, PubMed 21555307

Melki D, Lind S, Agewall S, Jernberg T (2011)
Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations
Scand Cardiovasc J, 45 (4), 198-204
DOI 10.3109/14017431.2011.565792, PubMed 21428843

Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, Dagfinrud H, Angel K, Atar D, Kvien TK (2011)
Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study
Ann Rheum Dis, 70 (5), 812-7
DOI 10.1136/ard.2010.141523, PubMed 21288959

Provan SA, Angel K, Semb AG, Mowinckel P, Agewall S, Atar D, Kvien TK (2011)
Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis
J Rheumatol, 38 (4), 606-12
DOI 10.3899/jrheum.100689, PubMed 21239744

Ghanavatian S, Stein RA, Atar D, Hole L, Agewall S (2011)
The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction
Clin Lab, 57 (9-10), 771-6
PubMed 22029194

Von Lueder TG, Melsom MN, Atar D, Agewall S (2011)
Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels
Clin Lab, 57 (7-8), 615-8
PubMed 21888026

Hallén J, Madsen L, Ladefoged S, Fagerland MW, Serebruany VL, Agewall S, Atar D (2010)
Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease
Scand J Urol Nephrol, 45 (2), 151-8
DOI 10.3109/00365599.2010.529819, PubMed 21091090

Roshan F, Saeed M, Agewall S (2010)
Patients' self-estimated likelihood of taking a statin as prescribed after different types of prognostic information
Atherosclerosis, 212 (2), 586-8
DOI 10.1016/j.atherosclerosis.2010.07.020, PubMed 20708186

Eriksson M, Uddén J, Hemmingsson E, Agewall S (2010)
Impact of physical activity and body composition on heart function and morphology in middle-aged, abdominally obese women
Clin Physiol Funct Imaging, 30 (5), 354-359
DOI 10.1111/j.1475-097X.2010.00952.x, PubMed 20646010

Henareh L, Camilla J, Jogestrand T, Brodin LA, Agewall S (2010)
Intima-media thickness of common carotid and brachial arteries and prothrombin fragment 1 + 2 are associated with left ventricular diastolic dysfunction in patients with myocardial infarction
Echocardiography, 27 (6), 651-8
DOI 10.1111/j.1540-8175.2009.01095.x, PubMed 20412272

Milonas C, Jernberg T, Lindbäck J, Agewall S, Wallentin L, Stenestrand U, RIKS-HIA Group (2010)
Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction
Am J Cardiol, 105 (9), 1229-34
DOI 10.1016/j.amjcard.2009.12.032, PubMed 20403471

Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I, Vahanian A et al. (2010)
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA)
Eur J Anaesthesiol, 27 (2), 92-137
DOI 10.1097/EJA.0b013e328334c017, PubMed 20068416

De Blois J, Simard S, Atar D, Agewall S, Norwegian Heart Failure Registry (2010)
COPD predicts mortality in HF: the Norwegian Heart Failure Registry
J Card Fail, 16 (3), 225-9
DOI 10.1016/j.cardfail.2009.12.002, PubMed 20206897

Brandsaeter B, Atar D, Agewall S, Norwegian Heart failure Registry (2009)
Gender differences among Norwegian patients with heart failure
Int J Cardiol, 146 (3), 354-8
DOI 10.1016/j.ijcard.2009.07.014, PubMed 19700210

Paier A, Agewall S, Kublickiene K (2009)
Expression of heat shock proteins and nitrotyrosine in small arteries from patients with coronary heart disease
Heart Vessels, 24 (4), 260-6
DOI 10.1007/s00380-008-1117-y, PubMed 19626397

Faizi AK, Kornmo DW, Agewall S (2009)
Evaluation of endothelial function using finger plethysmography
Clin Physiol Funct Imaging, 29 (5), 372-5
DOI 10.1111/j.1475-097X.2009.00882.x, PubMed 19552735

Henareh L, Jogestrand T, Agewall S (2009)
Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction
Thromb Res, 124 (5), 526-30
DOI 10.1016/j.thromres.2009.03.014, PubMed 19427679

Crisby M, Kublickiene K, Henareh L, Agewall S (2009)
Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease
Heart Vessels, 24 (2), 90-5
DOI 10.1007/s00380-008-1089-y, PubMed 19337791

Agewall S, Henareh L (2008)
Quality of life and insulin resistance in patients with coronary heart disease
Coron Artery Dis, 19 (5), 289-92
DOI 10.1097/MCA.0b013e3282fc618f, PubMed 18607164

Agewall S (2008)
[Five different types of myocardial infarction defined by new guidelines]
Lakartidningen, 105 (16), 1192-3
PubMed 18522260

Fox KA, Antman EM, Montalescot G, Agewall S, SomaRaju B, Verheugt FW, Lopez-Sendon J, Hod H, Murphy SA, Braunwald E (2007)
The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial
J Am Coll Cardiol, 49 (23), 2249-55
DOI 10.1016/j.jacc.2006.12.049, PubMed 17560289

Agewall S, Olsson T, Löwbeer C (2007)
Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit
Am J Cardiol, 99 (10), 1357-9
DOI 10.1016/j.amjcard.2006.12.059, PubMed 17493459

Cruz MN, Agewall S, Schenck-Gustafsson K, Kublickiene K (2007)
Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease
Atherosclerosis, 196 (1), 49-58
DOI 10.1016/j.atherosclerosis.2007.01.038, PubMed 17367797

Henareh L, Lind B, Brodin LA, Agewall S (2007)
Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue Doppler imaging in patients with myocardial infarction
Clin Physiol Funct Imaging, 27 (1), 60-6
DOI 10.1111/j.1475-097X.2007.00717.x, PubMed 17204040

Agewall S, Hernberg A (2006)
Atorvastatin normalizes endothelial function in healthy smokers
Clin Sci (Lond), 111 (1), 87-91
DOI 10.1042/CS20060033, PubMed 16608440

Agewall S, Norman B (2006)
Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease
Pathophysiol Haemost Thromb, 35 (6), 440-4
DOI 10.1159/000102051, PubMed 17565237

Henareh L, Jogestrand T, Agewall S (2006)
Microalbuminuria in patients with previous myocardial infarction
Kidney Int, 69 (1), 178-83
DOI 10.1038/sj.ki.5000026, PubMed 16374441

Cruz MN, Luksha L, Logman H, Poston L, Agewall S, Kublickiene K (2005)
Acute responses to phytoestrogens in small arteries from men with coronary heart disease
Am J Physiol Heart Circ Physiol, 290 (5), H1969-75
DOI 10.1152/ajpheart.01065.2005, PubMed 16361368

Henareh L, Jogestrand T, Agewall S (2005)
Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease
Diabet Med, 22 (9), 1212-7
DOI 10.1111/j.1464-5491.2005.01577.x, PubMed 16108851

Rohani M, Jogestrand T, Källner G, Jussila R, Agewall S (2005)
Morphological changes rather than flow-mediated dilatation in the brachial artery are better indicators of the extent and severity of coronary artery disease
J Hypertens, 23 (7), 1397-402
DOI 10.1097/01.hjh.0000173523.80802.94, PubMed 15942463

Agewall S, Henareh L, Kublickiene K (2005)
Endothelial function in conduit and resistance arteries in men with coronary disease
Atherosclerosis, 184 (1), 130-6
DOI 10.1016/j.atherosclerosis.2005.03.025, PubMed 15979080

Agewall S, Löwbeer C (2005)
The new definition of myocardial infarction--can we use it?
Clin Cardiol, 28 (2), 77-80
DOI 10.1002/clc.4960280207, PubMed 15757078

Agewall S, Henareh L, Jogestrand T (2005)
Intima-media complex of both the brachial artery and the common carotid artery are associated with left ventricular hypertrophy in patients with previous myocardial infarction
J Hypertens, 23 (1), 119-25
DOI 10.1097/00004872-200501000-00021, PubMed 15643133

Rohani M, Jogestrand T, Ekberg M, van der Linden J, Källner G, Jussila R, Agewall S (2004)
Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease
Atherosclerosis, 179 (2), 311-6
DOI 10.1016/j.atherosclerosis.2004.10.012, PubMed 15777547

Hansell J, Henareh L, Agewall S, Norman M (2004)
Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery
Clin Physiol Funct Imaging, 24 (6), 317-22
DOI 10.1111/j.1475-097X.2004.00575.x, PubMed 15522039

Henareh L, Berglund M, Agewall S (2004)
Should oral glucose tolerance test be a routine examination after a myocardial infarction?
Int J Cardiol, 97 (1), 21-4
DOI 10.1016/j.ijcard.2003.06.023, PubMed 15336801

Agewall S, Berglund M, Henareh L (2004)
Reduced quality of life after myocardial infarction in women compared with men
Clin Cardiol, 27 (5), 271-4
DOI 10.1002/clc.4960270506, PubMed 15188941

Rohani M, Agewall S (2004)
Oral snuff impairs endothelial function in healthy snuff users
J Intern Med, 255 (3), 379-83
DOI 10.1046/j.1365-2796.2003.01279.x, PubMed 14871462

Whalley GA, Gamble GD, Walsh HJ, Wright SP, Agewall S, Sharpe N, Doughty RN (2004)
Effect of tissue harmonic imaging and contrast upon between observer and test-retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure
Eur J Heart Fail, 6 (1), 85-93
DOI 10.1016/j.ejheart.2003.09.011, PubMed 15012923

Agewall S (2003)
Evaluation of point-of-care test systems using the new definition of myocardial infarction
Clin Biochem, 36 (1), 27-30
DOI 10.1016/s0009-9120(02)00417-4, PubMed 12554056

Agewall S, Björn F (2002)
Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men
Atherosclerosis, 164 (1), 161-6
DOI 10.1016/s0021-9150(02)00056-4, PubMed 12119205

Agewall S, Björn F (2002)
Urinary albumin excretion and insulin metabolism in clinically healthy 58-year-old men
Metabolism, 51 (6), 750-3
DOI 10.1053/meta.2002.32805, PubMed 12037729

Agewall S, Fagerberg B (2002)
Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men
Clin Cardiol, 25 (6), 287-90
DOI 10.1002/clc.4960250609, PubMed 12058792

Agewall S, Hulthe J, Fagerberg B, Gottfridsson B, Wikstrand J (2002)
Post-occlusion brachial artery vasodilatation after ischaemic handgrip exercise is nitric oxide mediated
Clin Physiol Funct Imaging, 22 (1), 18-23
DOI 10.1046/j.1475-097x.2002.00388.x, PubMed 12003093

Agewall S, Persson B, Lindstedt G, Fagerberg B (2002)
Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination
Br J Biomed Sci, 59 (3), 145-9
DOI 10.1080/09674845.2002.11783651, PubMed 12371055

Agewall S, Lindstedt G, Fagerberg B (2001)
Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men
Atherosclerosis, 157 (1), 197-202
DOI 10.1016/s0021-9150(00)00706-1, PubMed 11427221

Agewall S, Fagerberg B, Berglund G, Schmidt C, Wendelhag I, Wikstrand J, Risk Factor Intervention Study Group, Sweden (2001)
Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up
J Intern Med, 249 (4), 305-14
DOI 10.1046/j.1365-2796.2001.00818.x, PubMed 11298850

Agewall S (2001)
Should we do an oral glucose tolerance test in hypertensive men with normal fasting blood-glucose?
J Hum Hypertens, 15 (1), 71-4
DOI 10.1038/sj.jhh.1001136, PubMed 11224005

Agewall S, Doughty RN, Bagg W, Whalley GA, Braatvedt G, Sharpe N (2001)
Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions
Clin Physiol, 21 (1), 9-14
DOI 10.1046/j.1365-2281.2001.00302.x, PubMed 11168291

Agewall S, Bokemark L, Wikstrand J, Lindahl A, Fagerberg B (2000)
Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old men
Thromb Haemost, 84 (4), 571-5
PubMed 11057852

Schmidt C, Hulthe J, Wikstrand J, Gnarpe H, Gnarpe J, Agewall S, Fagerberg B (2000)
Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness
Stroke, 31 (7), 1526-31
DOI 10.1161/01.str.31.7.1526, PubMed 10884448

Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N (2000)
Does a glass of red wine improve endothelial function?
Eur Heart J, 21 (1), 74-8
DOI 10.1053/euhj.1999.1759, PubMed 10610747

Agewall S (1999)
Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group
J Intern Med, 246 (5), 489-95
DOI 10.1046/j.1365-2796.1999.00543.x, PubMed 10583718

Agewall S, Whalley GA, Doughty RN, Sharpe N (1999)
Handgrip exercise increases postocclusion hyperaemic brachial artery dilatation
Heart, 82 (1), 93-5
DOI 10.1136/hrt.82.1.93, PubMed 10377317

Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J (1999)
Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension
Stroke, 30 (2), 299-305
DOI 10.1161/01.str.30.2.299, PubMed 9933263

Agewall S, Wikstrand J, Fagerberg B (1998)
Stroke was predicted by dimensions of quality of life in treated hypertensive men
Stroke, 29 (11), 2329-33
DOI 10.1161/01.str.29.11.2329, PubMed 9804643

Agewall S, Wikstrand J, Fagerberg B (1998)
Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men
J Hypertens, 16 (4), 537-41
DOI 10.1097/00004872-199816040-00016, PubMed 9797200

Fagerberg B, Wikstrand J, Berglund G, Samuelsson O, Agewall S (1998)
Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention study
Am J Hypertens, 11 (1 Pt 1), 14-22
DOI 10.1016/s0895-7061(97)00363-4, PubMed 9504445

Agewall S, Wikstrand J, Ljungman S, Fagerberg B (1997)
Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group
Am J Cardiol, 80 (2), 164-9
DOI 10.1016/s0002-9149(97)00312-3, PubMed 9230153

Fagerberg B, Wiklund O, Agewall S, Camejo G, Wikstrand RJ (1996)
Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans
Eur J Clin Invest, 26 (11), 960-5
DOI 10.1046/j.1365-2362.1996.2030543.x, PubMed 8957200

Agewall S, Fagerberg B (1996)
Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Factor Intervention Study Group
Angiology, 47 (10), 963-72
DOI 10.1177/000331979604701005, PubMed 8873582

Suurküla M, Fagerberg B, Wendelhag I, Agewall S, Wikstrand J (1996)
Atherosclerotic disease in the femoral artery in hypertensive patients at high cardiovascular risk. The value of ultrasonographic assessment of intima-media thickness and plaque occurrence. Risk Intervention Study (RIS) Group
Arterioscler Thromb Vasc Biol, 16 (8), 971-7
DOI 10.1161/01.atv.16.8.971, PubMed 8696961

Agewall S, Wikstrand J, Dahlöf C, Fagerberg B (1996)
Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk
Am J Hypertens, 9 (6), 545-50
DOI 10.1016/0895-7061(95)00355-x, PubMed 8783778

Suurküla M, Agewall S, Fagerberg B, Wendelhag I, Wikstrand J (1996)
Multiple risk intervention in high-risk hypertensive patients. A 3-year ultrasound study of intima-media thickness and plaques in the carotid artery. Risk Intervention Study (RIS) Group
Arterioscler Thromb Vasc Biol, 16 (3), 462-70
DOI 10.1161/01.atv.16.3.462, PubMed 8630674

Agewall S, Wikstrand J, Wendelhag I, Tengborn L, Fagerberg B (1996)
Femoral artery wall morphology, hemostatic factors and intermittent claudication: ultrasound study in men at high and low risk for atherosclerotic disease
Haemostasis, 26 (1), 45-57
DOI 10.1159/000217187, PubMed 8698278

Agewall S, Wikstrand J, Dahlöf C, Fagerberg B (1995)
A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk
J Hypertens, 13 (12 Pt 1), 1471-7
PubMed 8866910

Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J (1995)
Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk
Stroke, 26 (6), 956-60
DOI 10.1161/01.str.26.6.956, PubMed 7762045

Agewall S, Wikstrand J, Ljungman S, Herlitz H, Fagerberg B (1995)
Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group
Am J Hypertens, 8 (4 Pt 1), 337-42
DOI 10.1016/0895-7061(94)00246-8, PubMed 7619345

Agewall S, Wikstrand J, Ljungman S, Fagerberg B (1995)
Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with non-insulin-dependent diabetes mellitus
J Hypertens, 13 (4), 463-9
PubMed 7629407

Agewall S, Fagerberg B, Attvall S, Ljungman S, Urbanavicius V, Tengborn L, Wikstrand J (1995)
Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group
J Intern Med, 237 (2), 195-203
DOI 10.1111/j.1365-2796.1995.tb01161.x, PubMed 7852923

Johannesson M, Agewall S, Hartford M, Hedner T, Fagerberg B (1995)
The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive men
J Intern Med, 237 (1), 19-26
DOI 10.1111/j.1365-2796.1995.tb01135.x, PubMed 7830026

Agewall S, Wikstrand J, Samuelsson O, Persson B, Andersson OK, Fagerberg B (1994)
The efficacy of multiple risk factor intervention in treated hypertensive men during long-term follow up. Risk Factor Intervention Study Group
J Intern Med, 236 (6), 651-9
DOI 10.1111/j.1365-2796.1994.tb00858.x, PubMed 7989900

Agewall S, Wikstrand J, Suurküla M, Tengborn L, Fagerberg B (1994)
Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease
Blood Coagul Fibrinolysis, 5 (6), 895-904
DOI 10.1097/00001721-199412000-00005, PubMed 7893927

Fagerberg B, Agewall S, Berglund A, Wysocki M, Lundberg PA, Lindstedt G (1994)
Is carbohydrate-deficient transferrin in serum useful for detecting excessive alcohol consumption in hypertensive patients?
Clin Chem, 40 (11 Pt 1), 2057-63
PubMed 7955378

Fagerberg B, Agewall S, Urbanavicius V, Attvall S, Lundberg PA, Lindstedt G (1994)
Carbohydrate-deficient transferrin is associated with insulin sensitivity in hypertensive men
J Clin Endocrinol Metab, 79 (3), 712-5
DOI 10.1210/jcem.79.3.8077351, PubMed 8077351

Suurküla M, Agewall S, Fagerberg B, Wendelhag I, Widgren B, Wikstrand J (1994)
Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group
Arterioscler Thromb, 14 (8), 1297-304
DOI 10.1161/01.atv.14.8.1297, PubMed 8049191

Agewall S, Persson B, Samuelsson O, Ljungman S, Herlitz H, Fagerberg B (1993)
Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study Group
J Hypertens, 11 (4), 461-9
DOI 10.1097/00004872-199304000-00019, PubMed 8390516

Agewall S, Rhea B, Persson B, Karlberg B, Wallin G, Andersson OK (1991)
Reflexogenic neuronal and humoral responses to selective stimulation of low-pressure cardiopulmonary receptors in man
J Intern Med, 229 (2), 151-8
DOI 10.1111/j.1365-2796.1991.tb00323.x, PubMed 1847720

Persson B, Andersson OK, Hjemdahl P, Wysocki M, Agewall S, Wallin G (1989)
Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma
J Hypertens, 7 (9), 747-56
PubMed 2551959

Review articles

Drexel H, Tamargo J, Kaski JC, Lewis BS, Saely CH, Fraunberger P, Dobrev D, Komiyama M, Plattner T, Agewall S, Hasegawa K (2023)
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
Eur Heart J Cardiovasc Pharmacother, 9 (6), 570-582
DOI 10.1093/ehjcvp/pvad044, PubMed 37328424

Tamargo J, Kaski JC, Kimura T, Barton JC, Yamamoto K, Komiyama M, Drexel H, Lewis BS, Agewall S, Hasegawa K (2022)
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Eur Heart J Cardiovasc Pharmacother, 8 (7), 738-751
DOI 10.1093/ehjcvp/pvac040, PubMed 35848895

Tamargo J, Kjeldsen KP, Delpón E, Semb AG, Cerbai E, Dobrev D, Savarese G, Sulzgruber P, Rosano G, Borghi C, Wassmann S, Torp-Pedersen CT, Agewall S, Drexel H, Baumgartner I, Lewis B, Ceconi C, Kaski JC, Niessner A (2022)
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (4), 406-419
DOI 10.1093/ehjcvp/pvac005, PubMed 35092425

Drexel H, Pocock SJ, Lewis BS, Saely CH, Kaski JC, Rosano GMC, Tautermann G, Huber K, Dopheide JF, Mader A, Niessner A, Savarese G, Schmidt TA, Semb AG, Tamargo J, Wassmann S, Clodi M, Kjeldsen KP, Agewall S (2022)
Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (3), 302-310
DOI 10.1093/ehjcvp/pvab048, PubMed 34180504

Krogager ML, Kragholm K, Thomassen JQ, Søgaard P, Lewis BS, Wassmann S, Baumgartner I, Ceconi C, Schmidt TA, Kaski JC, Drexel H, Semb AG, Agewall S, Niessner A, Savarese G, Kjeldsen KP, Borghi C, Tamargo J, Torp-Pedersen C (2021)
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 7 (6), 557-567
DOI 10.1093/ehjcvp/pvab038, PubMed 33956964

Täger T, Atar D, Agewall S, Katus HA, Grundtvig M, Cleland JGF, Clark AL, Fröhlich H, Frankenstein L (2021)
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Heart Fail Rev, 26 (6), 1421-1435
DOI 10.1007/s10741-020-09954-8, PubMed 32314085

Drexel H, Lewis BS, Rosano GMC, Saely CH, Tautermann G, Huber K, Dopheide JF, Kaski JC, Mader A, Niessner A, Savarese G, Schmidt TA, Semb A, Tamargo J, Wassmann S, Per Kjeldsen K, Agewall S, Pocock SJ (2021)
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
Eur Heart J Cardiovasc Pharmacother, 7 (5), 453-459
DOI 10.1093/ehjcvp/pvaa126, PubMed 33135079

Täger T, Frankenstein L, Atar D, Agewall S, Frey N, Grundtvig M, Clark AL, Cleland JGF, Fröhlich H (2021)
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis
Clin Res Cardiol, 111 (4), 428-439
DOI 10.1007/s00392-021-01913-z, PubMed 34498169

Drexel H, Rosano GMC, Lewis BS, Huber K, Vonbank A, Dopheide JF, Mader A, Niessner A, Savarese G, Wassmann S, Agewall S (2020)
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
Eur Heart J Cardiovasc Pharmacother, 6 (2), 97-103
DOI 10.1093/ehjcvp/pvz029, PubMed 31298686

Savarese G, Reiner MF, Uijl A, D'Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS (2020)
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
Eur Heart J Cardiovasc Pharmacother, 6 (2), 86-93
DOI 10.1093/ehjcvp/pvz036, PubMed 31392312

Hollan I, Ronda N, Dessein P, Agewall S, Karpouzas G, Tamargo J, Niessner A, Savarese G, Rosano G, Kaski JC, Wassmann S, Meroni PL (2020)
Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 6 (2), 104-114
DOI 10.1093/ehjcvp/pvz033, PubMed 31397840

Rosano GM, Spoletini I, Vitale C, Agewall S (2019)
Hyperkalemia and Renin-Angiotensin-Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
Card Fail Rev, 5 (3), 130-132
DOI 10.15420/cfr.2019.8.2, PubMed 31768268

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A (2019)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Eur Heart J Cardiovasc Pharmacother, 5 (3), 171-180
DOI 10.1093/ehjcvp/pvz016, PubMed 31119266

Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA (2019)
Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
Eur Heart J Cardiovasc Pharmacother, 5 (1), 47-54
DOI 10.1093/ehjcvp/pvy038, PubMed 30247574

Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Schmidt TA, Saely CH, Baumgartner I, Tamargo J (2018)
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
Eur Heart J Cardiovasc Pharmacother, 4 (4), 230-236
DOI 10.1093/ehjcvp/pvy028, PubMed 30099530

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2018)
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Int J Cardiol, 272, 260-266
DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995

Aboyans V, Björck M, Brodmann M, Collet JP, Czerny M, De Carlo M, Naylor AR, Roffi M, Tendera M, Vlachopoulos C, Ricco JB, Task Force for the 2017 ESC Guidelines for the diagnosis and management of Peripheral Arterial Diseases, in collaboration with the ESVS, Document Reviewers, Widimsky P, Kolh P, Dick F, Vega de Ceniga M, Piepoli MF, Sievert H, Sulzenko J, Esc Committee For Practice Guidelines Cpg, Windecker S, Aboyans V, Agewall S, Barbato E et al. (2018)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Eur J Vasc Endovasc Surg, 55 (4), 457-464
DOI 10.1016/j.ejvs.2017.08.014, PubMed 29628287

Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, Document Reviewers, Widimsky P et al. (2017)
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Eur J Vasc Endovasc Surg, 55 (3), 305-368
DOI 10.1016/j.ejvs.2017.07.018, PubMed 28851596

Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, Ceconi C, Drexel H, Kjeldsen K, Savarese G, Torp-Pedersen C, Atar D, Lewis BS, Agewall S (2017)
Gender differences in the effects of cardiovascular drugs
Eur Heart J Cardiovasc Pharmacother, 3 (3), 163-182
DOI 10.1093/ehjcvp/pvw042, PubMed 28329228

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H et al. (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Eur J Heart Fail, 19 (1), 9-42
DOI 10.1002/ejhf.654, PubMed 27565769

Gresslien T, Agewall S (2016)
Troponin and exercise
Int J Cardiol, 221, 609-21
DOI 10.1016/j.ijcard.2016.06.243, PubMed 27420587

Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C (2016)
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J, 37 (13), 1015-23
DOI 10.1093/eurheartj/ehv505, PubMed 26984863

Ellingsrud C, Agewall S (2015)
Morphine in the treatment of acute pulmonary oedema--Why?
Int J Cardiol, 202, 870-3
DOI 10.1016/j.ijcard.2015.10.014, PubMed 26476045

Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D'Agostino RB, Kubica J, Volpe M, Agewall S, Kereiakes DJ, Kelm M (2015)
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis
Ann Intern Med, 163 (1), 40-51
DOI 10.7326/M14-2957, PubMed 25915661

Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, Cohen-Tervaert JW, Maki-Petaja K, Grundtvig M, Karpouzas GA, Meroni PL (2015)
Prevention of cardiovascular disease in rheumatoid arthritis
Autoimmun Rev, 14 (10), 952-69
DOI 10.1016/j.autrev.2015.06.004, PubMed 26117596

Rubboli A, Agewall S, Huber K, Lip GY (2015)
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint
Int J Cardiol, 196, 133-8
DOI 10.1016/j.ijcard.2015.06.006, PubMed 26093527

Ladeiras-Lopes R, Agewall S, Tawakol A, Staels B, Stein E, Mentz RJ, Leite-Moreira A, Zannad F, Koenig W (2015)
Atherosclerosis: Recent trials, new targets and future directions
Int J Cardiol, 192, 72-81
DOI 10.1016/j.ijcard.2015.05.013, PubMed 26002254

Ellingsrud C, Agewall S (2014)
[Morphine in the treatment of acute pulmonary oedema]
Tidsskr Nor Laegeforen, 134 (23-24), 2272-5
DOI 10.4045/tidsskr.14.0359, PubMed 25492336

Anker SD, Agewall S, Borggrefe M, Calvert M, Jaime Caro J, Cowie MR, Ford I, Paty JA, Riley JP, Swedberg K, Tavazzi L, Wiklund I, Kirchhof P (2014)
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
Eur Heart J, 35 (30), 2001-9
DOI 10.1093/eurheartj/ehu205, PubMed 24904027

Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O'Connor CM (2013)
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges
Int J Cardiol, 167 (5), 1772-82
DOI 10.1016/j.ijcard.2012.12.018, PubMed 23298559

Agewall S, DeGroot E, Marcos-Alberca P, Zamorano JL, Barrero AA, Badano LP, Perrone-Filardi P (2012)
Ultrasound and radiology surrogate endpoints in pharmacological studies
Atherosclerosis, 224 (1), 12-24
DOI 10.1016/j.atherosclerosis.2012.03.038, PubMed 22632921

Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegría E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs RH, Kjekshus JK, Perrone Filardi P, Riccardi G, Storey RF, David W, Clinical Practice Guidelines Committee of the Spanish Society of Cardiology (2011)
[ESC/EAS Guidelines for the management of dyslipidaemias]
Rev Esp Cardiol, 64 (12), 1168.e1-1168.e60
DOI 10.1016/j.recesp.2011.09.014, PubMed 22115524

Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) (2011)
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Atherosclerosis, 217 (1), 3-46
DOI 10.1016/j.atherosclerosis.2011.06.028, PubMed 21882396

Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees (2011)
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Atherosclerosis, 217 Suppl 1, S1-44
DOI 10.1016/j.atherosclerosis.2011.06.012, PubMed 21723445

Agewall S, Eurenius L, Hofman-Bang C, Malmqvist K, Frick M, Jernberg T, Tornvall P (2011)
Myocardial infarction with angiographically normal coronary arteries
Atherosclerosis, 219 (1), 10-4
DOI 10.1016/j.atherosclerosis.2011.04.036, PubMed 21601856

Agewall S, Giannitsis E, Jernberg T, Katus H (2010)
Troponin elevation in coronary vs. non-coronary disease
Eur Heart J, 32 (4), 404-11
DOI 10.1093/eurheartj/ehq456, PubMed 21169615

Agewall S, Badimon L, Drouet L, Eschenhagen T, Husted S, Simon T, Steg G (2010)
Oral antiplatelet agents in ACS: from pharmacology to clinical differences
Fundam Clin Pharmacol, 25 (5), 564-71
DOI 10.1111/j.1472-8206.2010.00890.x, PubMed 21077944

Bäck M, Ketelhuth DF, Agewall S (2010)
Matrix metalloproteinases in atherothrombosis
Prog Cardiovasc Dis, 52 (5), 410-28
DOI 10.1016/j.pcad.2009.12.002, PubMed 20226959

Luksha L, Agewall S, Kublickiene K (2008)
Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease
Atherosclerosis, 202 (2), 330-44
DOI 10.1016/j.atherosclerosis.2008.06.008, PubMed 18656197

Skeppholm M, Agewall S, Ljungman P, Daniel M, Eriksson M, Hofman-Bang C, Malmqvist K, Reistam U, Svane B, Tornvall P (2007)
[Myocardial infarction with normal coronary arteries in women. MINCA--a specific type of myocardial infarction]
Lakartidningen, 104 (37), 2586-8
PubMed 17970392

Agewall S (2003)
Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor?
Curr Vasc Pharmacol, 1 (2), 107-9
DOI 10.2174/1570161033476745, PubMed 15320837

Agewall S, Kendall M (1997)
Treatment with beta-blockers--the value of an even plasma concentration over 24 h
J Clin Pharm Ther, 22 (3), 171-9
DOI 10.1046/j.1365-2710.1997.8775087.x, PubMed 9447471

Other articles

Tamargo J, Agewall S (2023)
Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated
Eur Heart J, 44 (42), 4485-4487
DOI 10.1093/eurheartj/ehad660, PubMed 37862581

Agewall S (2023)
Antiplatelet treatment after PCI
Eur Heart J Cardiovasc Pharmacother, 9 (7), 593-594
DOI 10.1093/ehjcvp/pvad071, PubMed 37846590

Agewall S (2023)
Cardiovascular preventive actions
Eur Heart J Cardiovasc Pharmacother, 9 (6), 497-498
DOI 10.1093/ehjcvp/pvad054, PubMed 37727121

Sundqvist MG, Sörensson P, Ekenbäck C, Lundin M, Agewall S, Brolin EB, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Caidahl K, Ugander M, Tornvall P (2023)
CMR Is Often Abnormal Despite Normal Echocardiography in Suspected Myocardial Infarction With Nonobstructed Coronary Arteries
JACC Cardiovasc Imaging, 16 (12), 1626-1628
DOI 10.1016/j.jcmg.2023.05.024, PubMed 37498255

Schneider A, Atar D, Agewall S (2023)
RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action
J Am Coll Cardiol, 81 (11), 1130-1132
DOI 10.1016/j.jacc.2022.10.041, PubMed 36922095

Agewall S (2023)
Focus on lipid treatment
Eur Heart J Cardiovasc Pharmacother, 9 (2), 119-120
DOI 10.1093/ehjcvp/pvad007, PubMed 36727481

Agewall S (2022)
Pharmacological treatment of CVD
Eur Heart J Cardiovasc Pharmacother, 9 (1), 1-3
DOI 10.1093/ehjcvp/pvac068, PubMed 36519600

Agewall S (2022)
Future of European Heart Journal Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 8 (8), 753
DOI 10.1093/ehjcvp/pvac061, PubMed 36458859

Agewall S (2022)
To treat or not to treat
Eur Heart J Cardiovasc Pharmacother, 8 (8), 754-755
DOI 10.1093/ehjcvp/pvac062, PubMed 36458860

Tamargo J, Hasegawa K, Agewall S (2022)
Toward personalized medicine for cardiovascular pharmacotherapy
Eur Heart J, 43 (45), 4719-4721
DOI 10.1093/eurheartj/ehac413, PubMed 35924414

Nickander J, Ekenbäck C, Agewall S, Bacsovics Brolin E, Caidahl K, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Sundqvist M, Ugander M, Tornvall P, Sörensson P (2022)
Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
JACC Cardiovasc Imaging, 16 (1), 128-129
DOI 10.1016/j.jcmg.2022.07.021, PubMed 36599558

De Caterina R, Agewall S, Andreotti F, Angiolillo DJ, Bhatt DL, Byrne RA, Collet JP, Eikelboom J, Fanaroff AC, Gibson CM, Goette A, Hindricks G, Lip GYH, Potpara T, Thiele H, Lopes RD, Galli M (2022)
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
Eur Heart J, 43 (37), 3512-3527
DOI 10.1093/eurheartj/ehac294, PubMed 35925556

Agewall S (2022)
Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding
Eur Heart J Cardiovasc Pharmacother, 8 (7), 645-647
DOI 10.1093/ehjcvp/pvac048, PubMed 36172980

Agewall S (2022)
Prevention is still the key to success
Eur Heart J Cardiovasc Pharmacother, 8 (6), 537-538
DOI 10.1093/ehjcvp/pvac046, PubMed 36057770

Agewall S (2022)
Focus on optimizing treatment of coronary heart disease
Eur Heart J Cardiovasc Pharmacother, 8 (5), 431-433
DOI 10.1093/ehjcvp/pvac039, PubMed 35856265

Agewall S (2022)
Focus on different aspects of atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 8 (4), 323-324
DOI 10.1093/ehjcvp/pvac035, PubMed 35674202

Agewall S (2022)
New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials
Eur Heart J Cardiovasc Pharmacother, 8 (3), 213-215
DOI 10.1093/ehjcvp/pvac019, PubMed 35435962

Agewall S (2022)
Optimizing individual heart failure treatment
Eur Heart J Cardiovasc Pharmacother, 8 (2), 105-107
DOI 10.1093/ehjcvp/pvab087, PubMed 35039827

Agewall S (2022)
Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient
Eur Heart J Cardiovasc Pharmacother, 8 (1), 1-3
DOI 10.1093/ehjcvp/pvab078, PubMed 34984441

Agewall S (2021)
Unsolved pharmacological issues with cardiology
Eur Heart J Cardiovasc Pharmacother, 7 (6), 461-462
DOI 10.1093/ehjcvp/pvab077, PubMed 34734246

Agewall S (2021)
More knowledge about atrial fibrillation, still we need to learn
Eur Heart J Cardiovasc Pharmacother, 7 (5), 361-362
DOI 10.1093/ehjcvp/pvab067, PubMed 34545933

Tamargo J, Agewall S (2021)
Fluoroquinolone use and valvular heart disease: is the jury still out?
Eur Heart J, 42 (30), 2909-2911
DOI 10.1093/eurheartj/ehab426, PubMed 34254116

Agewall S (2021)
Adherence to pharmacological treatment: how can we improve?
Eur Heart J Cardiovasc Pharmacother, 7 (4), 261-262
DOI 10.1093/ehjcvp/pvab049, PubMed 34298551

Agewall S (2021)
Different aspects of giving the optimal antiplatelet treatment
Eur Heart J Cardiovasc Pharmacother, 7 (3), 169-170
DOI 10.1093/ehjcvp/pvab037, PubMed 34023878

Agewall S (2021)
Antiplatelet treatment in coronary syndrome
Eur Heart J Cardiovasc Pharmacother, 7 (2), 81-82
DOI 10.1093/ehjcvp/pvab015, PubMed 33720341

Agewall S (2021)
Atrial fibrillation in registries
Eur Heart J Cardiovasc Pharmacother, 7 (1), 1-2
DOI 10.1093/ehjcvp/pvaa142, PubMed 33367509

Agewall S (2020)
Focus on blood pressure and risk factor intervention
Eur Heart J Cardiovasc Pharmacother, 6 (6), 339-340
DOI 10.1093/ehjcvp/pvaa130, PubMed 33197927

Lewis BS, Agewall S, Rosano GMC (2020)
MSc in clinical trials: a new flagship Working Group project
Eur Heart J Cardiovasc Pharmacother, 6 (5), 284
DOI 10.1093/ehjcvp/pvaa078, PubMed 32614438

Agewall S (2020)
Minimizing bleeding events
Eur Heart J Cardiovasc Pharmacother, 6 (5), 271-272
DOI 10.1093/ehjcvp/pvaa100, PubMed 32932523

Agewall S (2020)
Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?
Eur Heart J Cardiovasc Pharmacother, 6 (4), 201-202
DOI 10.1093/ehjcvp/pvaa075, PubMed 32668002

Agewall S (2020)
Focus on subpopulations of atrial fibrillation patients
Eur Heart J Cardiovasc Pharmacother, 6 (3), 131-132
DOI 10.1093/ehjcvp/pvaa034, PubMed 32412082

Agewall S (2020)
Lipids and antithrombotic treatment
Eur Heart J Cardiovasc Pharmacother, 6 (2), 71
DOI 10.1093/ehjcvp/pvaa014, PubMed 32176294

Agewall S (2020)
Focus on pharma in acute coronary syndrome
Eur Heart J Cardiovasc Pharmacother, 6 (1), 1-2
DOI 10.1093/ehjcvp/pvz074, PubMed 31909430

Agewall S (2019)
European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723
Eur Heart J Cardiovasc Pharmacother, 5 (4), 183-184
DOI 10.1093/ehjcvp/pvz041, PubMed 31531677

Agewall S (2019)
Antiplatelet treatment in acute coronary syndrome. Still an issue
Eur Heart J Cardiovasc Pharmacother, 5 (3), 125-126
DOI 10.1093/ehjcvp/pvz018, PubMed 31210265

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Eur Heart J Cardiovasc Pharmacother, 5 (2), 62-63
DOI 10.1093/ehjcvp/pvz001, PubMed 30689786

Agewall S (2019)
Unsolved issues in oral anticoagulation treatment in atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 5 (2), 60-61
DOI 10.1093/ehjcvp/pvz008, PubMed 30874812

Marciniak TA, Hall TS, Atar D, Agewall S, Serebruany VL (2019)
Ivabradine for heart failure: regulatory differences in Europe and United States
Eur Heart J Cardiovasc Pharmacother, 5 (2), 119-121
DOI 10.1093/ehjcvp/pvz006, PubMed 30715322

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: vet the message!
Eur Heart J Qual Care Clin Outcomes, 5 (2), 83-84
DOI 10.1093/ehjqcco/qcy057, PubMed 30689789

Agewall S (2019)
European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
Eur Heart J Cardiovasc Pharmacother, 5 (2), 59
DOI 10.1093/ehjcvp/pvz009, PubMed 30874813

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation
Hypertension, 73 (3), 506-507
DOI 10.1161/HYPERTENSIONAHA.118.12518, PubMed 30686083

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation: Vet the Message!
Int J Cardiol, 277, 1-2
DOI 10.1016/j.ijcard.2018.12.071, PubMed 30661544

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation
Circ Cardiovasc Interv, 12 (2), e007796
DOI 10.1161/CIRCINTERVENTIONS.119.007796, PubMed 30688520

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation
Circ Genom Precis Med, 12 (2), e002439
DOI 10.1161/CIRCGEN.118.002439, PubMed 30688515

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation
Circ Cardiovasc Imaging, 12 (2), e008809
DOI 10.1161/CIRCIMAGING.118.008809, PubMed 30688516

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation: Vet the Message!
J Cardiovasc Pharmacol, 73 (2), 61-62
DOI 10.1097/FJC.0000000000000648, PubMed 30730472

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol C, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation
Circ Cardiovasc Qual Outcomes, 12 (2), e005496
DOI 10.1161/CIRCOUTCOMES.119.005496, PubMed 30688519

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation
Circ Heart Fail, 12 (2), e005869
DOI 10.1161/CIRCHEARTFAILURE.119.005869, PubMed 30688079

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical Misinformation
Circulation, 139 (5), 571-572
DOI 10.1161/CIRCULATIONAHA.118.039193, PubMed 30689419

Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
Medical misinformation: Vet the message!
Heart Rhythm, 16 (3), 332-333
DOI 10.1016/j.hrthm.2018.12.030, PubMed 30703343

Agewall S (2019)
Old and new drugs in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (1), 1-2
DOI 10.1093/ehjcvp/pvy046, PubMed 30615170

Agewall S (2018)
Adherence to guidelines, compliance to treatment, and treatment quality
Eur Heart J Cardiovasc Pharmacother, 4 (4), 189-190
DOI 10.1093/ehjcvp/pvy033, PubMed 32420591

Niessner A, Agewall S (2018)
Critical appraisal of the COMPASS trial
Eur Heart J Cardiovasc Pharmacother, 4 (4), 191-192
DOI 10.1093/ehjcvp/pvy027, PubMed 30113628

Agewall S (2018)
New input on antiplatelet treatment and registry studies
Eur Heart J Cardiovasc Pharmacother, 4 (3), 129-130
DOI 10.1093/ehjcvp/pvy016, PubMed 30052852

von Lueder TG, Agewall S (2018)
The burden of heart failure in the general population: a clearer and more concerning picture
J Thorac Dis, 10 (Suppl 17), S1934-S1937
DOI 10.21037/jtd.2018.04.153, PubMed 30023084

Agewall S (2018)
Cardiovascular pharmacotherapy and real-world data
Eur Heart J Cardiovasc Pharmacother, 4 (2), 65-66
DOI 10.1093/ehjcvp/pvy008, PubMed 29554294

Agewall S (2018)
Cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 4 (1), 1
DOI 10.1093/ehjcvp/pvx036, PubMed 29315398

Atar D, Agewall S (2017)
"False positive troponin values" are not found
Tidsskr. Nor. Laegeforen., 137 (23-24), 1859

Atar D, Agewall S (2017)
[Not Available]
Tidsskr Nor Laegeforen, 137 (23-24)
DOI 10.4045/tidsskr.17.0967, PubMed 29231634

Kaluzna-Oleksy M, Aunan K, Rao-Skirbekk S, Kjellstrom T, Ezekowitz JA, Agewall S, Atar D (2017)
Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017
Scand Cardiovasc J, 52 (1), 1-3
DOI 10.1080/14017431.2017.1405069, PubMed 29202608

Agewall S (2017)
European Heart Journal - Cardiovascular Pharmacotherapy: A fast growing baby-filling an important gap in the literature
Eur Heart J, 38 (44), 3251
DOI 10.1093/eurheartj/ehx619, PubMed 29177414

Agewall S (2017)
Adherence to guidelines and registry data
Eur Heart J Cardiovasc Pharmacother, 3 (4), 183-184
DOI 10.1093/ehjcvp/pvx027, PubMed 28922837

Agewall S (2017)
Metabolic control, anticoagulation, and gender aspects
Eur Heart J Cardiovasc Pharmacother, 3 (3), 125-126
DOI 10.1093/ehjcvp/pvx014, PubMed 28863427

Agewall S (2017)
Morphine in acute heart failure
J Thorac Dis, 9 (7), 1851-1854
DOI 10.21037/jtd.2017.06.129, PubMed 28839982

Agewall S, Camm J (2017)
New ESC/EACTS Guidelines for the management of atrial fibrillation
Eur Heart J Cardiovasc Pharmacother, 3 (2), 71-72
DOI 10.1093/ehjcvp/pvw038, PubMed 28025214

Agewall S (2017)
Coronary artery disease and arrhythmias
Eur Heart J Cardiovasc Pharmacother, 3 (2), 69-70
DOI 10.1093/ehjcvp/pvx005, PubMed 28363208

Rubboli A, Agewall S, Huber K, Lip GYH (2017)
New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose
Eur J Intern Med, 40, e11-e12
DOI 10.1016/j.ejim.2017.01.003, PubMed 28087220

Agewall S (2017)
Anticoagulation, atherosclerosis, and heart failure
Eur Heart J Cardiovasc Pharmacother, 3 (1), 1-2
DOI 10.1093/ehjcvp/pvw037, PubMed 28062653

Agewall S (2016)
The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!
Eur Heart J Cardiovasc Pharmacother, 2 (4), 207-8
DOI 10.1093/ehjcvp/pvw021, PubMed 27600901

Agewall S, Lewis BS, Atar D (2016)
Cardiovascular pharmacotherapy
Int J Cardiol, 224, 412-415
DOI 10.1016/j.ijcard.2016.09.065, PubMed 27690338

Agewall S (2016)
News from EHJCVP
Eur Heart J Cardiovasc Pharmacother, 2 (3), 141
DOI 10.1093/ehjcvp/pvw010, PubMed 27533754

Schmidt M, Lamberts M, Olsen AM, Fosbøll EL, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C (2016)
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
Eur Heart J Cardiovasc Pharmacother, 2 (2), 108-18
DOI 10.1093/ehjcvp/pvv054, PubMed 27533522

Agewall S (2016)
Update from EHJ CVP
Eur Heart J Cardiovasc Pharmacother, 2 (2), 77-8
DOI 10.1093/ehjcvp/pvw004, PubMed 27533516

Agewall S (2016)
Second year of a journal
Eur Heart J Cardiovasc Pharmacother, 2 (1), 1-2
DOI 10.1093/ehjcvp/pvv049, PubMed 27533054

Lewis BS, Agewall S (2016)
Annual report of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 2 (1), 3-4
DOI 10.1093/ehjcvp/pvv050, PubMed 27533055

Atar D, Agewall S (2015)
Morphine in myocardial infarction: balancing on the tight rope
Eur Heart J, 37 (3), 253-5
DOI 10.1093/eurheartj/ehv546, PubMed 26491111

Agewall S (2015)
[Re: Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (15), 1337
DOI 10.4045/tidsskr.15.0761, PubMed 26315220

Agewall S (2015)
Starting up a new Journal within the European Heart Journal Family
Eur Heart J Cardiovasc Pharmacother, 1 (4), 213
DOI 10.1093/ehjcvp/pvv033, PubMed 27532442

Agewall S (2015)
Cardiovascular Pharmacotherapy is moving!
Eur Heart J Cardiovasc Pharmacother, 1 (3), 149
DOI 10.1093/ehjcvp/pvv025, PubMed 27533986

Agewall S (2015)
How to save six million people per year
Atherosclerosis, 240 (2), 387-8
DOI 10.1016/j.atherosclerosis.2015.04.006, PubMed 25881201

Agewall S (2015)
European Heart Journal - CVP: what is next?
Eur Heart J Cardiovasc Pharmacother, 1 (2), 73
DOI 10.1093/ehjcvp/pvv009, PubMed 27533970

Atar D, Agewall S (2015)
End of story? Studies on prevention of reperfusion injury encounter perpetual defeats
Eur Heart J Cardiovasc Pharmacother, 1 (1), 46-7
DOI 10.1093/ehjcvp/pvu018, PubMed 27533965

Agewall S (2015)
European Heart Journal - Cardiovascular Pharmacotherapy: a new journal within the European Heart Journal family
Eur Heart J Cardiovasc Pharmacother, 1 (1), 1
DOI 10.1093/ehjcvp/pvu022, PubMed 27533955

Agewall S (2014)
[Final reply: follow the Danish example]
Lakartidningen, 111 (9-10), 405
PubMed 24707558

Agewall S (2014)
[Why all these guidelines?]
Lakartidningen, 111 (5), 129
PubMed 24624760

Namtvedt SK, Hisdal J, Randby A, Agewall S, Røsjø H, Omland T (2013)
The author’s reply
Heart, 100 (1), 81-2
DOI 10.1136/heartjnl-2013-304648, PubMed 24014283

Agewall S (2013)
Sick leave and a smoking ban
Eur Heart J, 35 (5), 266-7
DOI 10.1093/eurheartj/eht178, PubMed 23739243

Hisdal J, Agewall S, Omland T (2013)
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity—the response
Heart, 99 (13), 969
DOI 10.1136/heartjnl-2013-303771, PubMed 23661637

Agewall S, Tornvall P (2013)
Thyroid dysfunction in patients with myocardial infarction with normal coronary arteries
Angiology, 64 (3), 245-6
DOI 10.1177/0003319712471071, PubMed 23299173

Santos RD, Agewall S (2012)
Non-alcoholic fatty liver disease and cardiovascular disease
Atherosclerosis, 224 (2), 324-5
DOI 10.1016/j.atherosclerosis.2012.07.018, PubMed 22840429

Griffin BA, Agewall S (2012)
Can increased arterial stiffness in women relative to men be explained by their progressive loss of gluteofemoral fat?
Atherosclerosis, 224 (2), 320-1
DOI 10.1016/j.atherosclerosis.2012.05.041, PubMed 22800649

Agewall S, Henareh L (2012)
Low self-estimated quality of life after myocardial infarction and future cardiovascular risk
Int J Cardiol, 157 (1), 128-9
DOI 10.1016/j.ijcard.2012.03.044, PubMed 22459393

Hjeltnes G, Hollan I, Førre Ø, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2012)
Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients
Scand J Rheumatol, 41 (3), 240-2
DOI 10.3109/03009742.2012.656698, PubMed 22401496

Rubba P, Agewall S (2011)
Early arterial abnormalities in young adulthood
Atherosclerosis, 220 (2), 319-20
DOI 10.1016/j.atherosclerosis.2011.08.008, PubMed 21899842

Tjora S, Gjestland H, Mordal S, Agewall S (2011)
Troponin rise in healthy subjects during exercise test
Int J Cardiol, 151 (3), 375-6
DOI 10.1016/j.ijcard.2011.06.106, PubMed 21764153

Agewall S (2011)
The large clinical statin trials
Int J Cardiol, 150 (1), 108-11
DOI 10.1016/j.ijcard.2011.04.029, PubMed 21621286

Wellnhofer E, Agewall S (2010)
Ivabradine: an hypothesis generating study--an important link between bench and bedside
Atherosclerosis, 215 (1), 32-3
DOI 10.1016/j.atherosclerosis.2010.12.016, PubMed 21236430

Barth J, Agewall S (2010)
Never too late: a commentary on "Impact of age, sex and exercise on brachial and popliteal artery remodelling in humans"
Atherosclerosis, 210 (2), 366
DOI 10.1016/j.atherosclerosis.2010.02.039, PubMed 20362291

Agewall S, Nesvold A (2009)
Sweet dreams might be bad
Int J Cardiol, 147 (1), 139-40
DOI 10.1016/j.ijcard.2009.08.044, PubMed 19765838

Agewall S, Atar D (2009)
Interpreting clinical trials: the 'beautiful' case
Fundam Clin Pharmacol, 23 (2), 261-2
DOI 10.1111/j.1472-8206.2009.00682.x, PubMed 19236485

Agewall S (2008)
Acute and stable coronary heart disease: different risk factors
Eur Heart J, 29 (16), 1927-9
DOI 10.1093/eurheartj/ehn321, PubMed 18621774

Kublickiene K, Agewall S (2007)
Gender issues in cardiovascular medicine
Gynecol Endocrinol, 23 (7), 363-5
DOI 10.1080/09513590701524507, PubMed 17701764

Saha S, Berglund M, Sylvén C, Gordon A, Agewall S (2007)
Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris
Int J Cardiol, 123 (2), 195-6
DOI 10.1016/j.ijcard.2006.11.136, PubMed 17320208

Agewall S, Atar D (2007)
Levosimendan: perpetuum mobile?
Eur Heart J, 28 (4), 515
DOI 10.1093/eurheartj/ehl487, PubMed 17283001

Agewall S, Henareh L, Jogestrand T, Norman B (2007)
Association between AMPD1 Gene Polymorphism and Coagulation Factors in Patients with Coronary Heart Disease (vol 35, pg 440, 2006)
Pathophysiol. Haemost. Thromb., 36 (2), 108

Agewall S (2005)
Matrix metalloproteinases and cardiovascular disease
Eur Heart J, 27 (2), 121-2
DOI 10.1093/eurheartj/ehi639, PubMed 16272213

Agewall S (2005)
How should we evaluate an open artery in STEMI patients?
Eur Heart J, 26 (7), 634-6
DOI 10.1093/eurheartj/ehi217, PubMed 15757956

Agewall S (2004)
[Bad taste in the mouth because of the article on snuff use]
Lakartidningen, 101 (39), 3018
PubMed 15493647

Agewall S (2004)
Snus is not harmless!
Eur J Epidemiol, 19 (8), 819
DOI 10.1023/b:ejep.0000036621.85569.90, PubMed 15469040

Agewall S (2003)
Clever idiot?
Lancet, 361 (9369), 1659
DOI 10.1016/S0140-6736(03)13292-8, PubMed 12747922

Agewall S (2003)
[A clever idiot?]
Lakartidningen, 100 (4), 250
PubMed 12580014

Agewall S (2000)
Increases of creatine kinase MB and cardiac troponin T in serum of a patient with uterine leiomyosarcoma
Clin Chem, 46 (12), 2016-7
PubMed 11106342